WealthStone’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$617K Buy
3,307
+517
+19% +$101K 0.22% 72
2020
Q4
$471K Sell
2,790
-163
-6% -$24.3K 0.17% 86
2020
Q3
$437K Buy
+2,953
New +$457K 0.2% 71
2019
Q3
Sell
-90
Closed -$9.97K 354
2019
Q2
$9.97K Buy
+90
New +$10.6K ﹤0.01% 258

Other funds holding LLY

WealthStone's LLY Position: Q1 2021 in Review

WealthStone increased its Eli Lilly (LLY) stake by 19% in Q1 2021, buying an estimated $101K and bringing the position to 3,307 shares worth $617K. The position accounts for 0.22% of the portfolio, ranked #72.

WealthStone first reported a position in LLY in Q2 2019 and has held it in 4 quarters since. 1,948 funds tracked by Wall St. Rank hold LLY as of Q1 2021.

  • WealthStone held 3,307 shares of Eli Lilly worth $617K as of Q1 2021.
  • WealthStone bought 517 Eli Lilly shares in Q1 2021, an estimated $101K.
  • Eli Lilly made up 0.22% of WealthStone's portfolio in Q1 2021, its #72 holding.
  • WealthStone first reported a position in Eli Lilly in Q2 2019 and has held it in 4 quarters since.
  • 1,948 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.

Based on WealthStone's 13F filing for Q1 2021, filed 13 May 2021.